2018
DOI: 10.4274/tnd.79836
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic-disability Biomarkers in Multiple Sclerosis: Review of the Literature from the Last Five Years

Abstract: With the advent of new agents in the treatment of multiple sclerosis, new treatment modalities have emerged (escalation-induction therapy) and the increased efficacy of the drugs has led to increased drug-related risks. The risk/benefit balance has become more carefully assessed. The increased need for reliable markers to predict prognosis-disability has also led to an increase in research conducted in this area. In this short review, studies published between 2012-2017, especially those related to prognosis a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 65 publications
0
1
0
Order By: Relevance
“…Different MRI predictors of MS disability which can be easily implemented in clinics have been proposed. [6][7][8][9] To date, these predictors have not been approved to be implemented in clinical practice. Predictors include white matter lesions (WMLs) accumulation 10,11 and linear measurements of brain atrophy.…”
Section: Introductionmentioning
confidence: 99%
“…Different MRI predictors of MS disability which can be easily implemented in clinics have been proposed. [6][7][8][9] To date, these predictors have not been approved to be implemented in clinical practice. Predictors include white matter lesions (WMLs) accumulation 10,11 and linear measurements of brain atrophy.…”
Section: Introductionmentioning
confidence: 99%